Viewing StudyNCT06416410



Ignite Creation Date: 2024-05-19 @ 5:35 PM
Last Modification Date: 2024-10-26 @ 3:29 PM
Study NCT ID: NCT06416410
Status: RECRUITING
Last Update Posted: 2024-05-20
First Post: 2024-05-09

Brief Title: JAB-21822 Combined With JAB-3312 Compared SOC in the First Line for Treatment of Advanced Non-small Cell Lung Cancer With KRAS pG12C Mutation
Sponsor: Jacobio Pharmaceuticals Co Ltd
Organization: Jacobio Pharmaceuticals Co Ltd

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-07-17
Start Date Type: ESTIMATED
Primary Completion Date: 2026-09-30
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-02-28
Completion Date Type: ESTIMATED
First Submit Date: 2024-05-09
First Submit QC Date: May 14 2024
Study First Post Date: 2024-05-16
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-08-29
Last Update Post Date: 2024-05-20
Last Update Post Date Type: ACTUAL